Skip to main content
Signal8

Cilento Richard C. Jr.

SEC insider (Form 3/4/5 filer). CIK 0002010661. Director at FibroBiologics, Inc. (FBLG). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in HOUSTON,, TX.

Companies Cilento Richard C. Jr. has filed insider reports for

  • FibroBiologics, Inc. (FBLG): Director
Cilento Richard C. Jr. profile photo

Cilento Richard C. Jr.

CIK: 0002010661

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FibroBiologics, Inc. logo
FBLG

FibroBiologics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • FibroBiologics, Inc. logo
    FBLG

    FibroBiologics, Inc.

    Jun 23, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    30.8K shares-
  • FibroBiologics, Inc. logo
    FBLG

    FibroBiologics, Inc.

    Jun 12, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    22K shares-

1-2 of 2